Caplyta Versus Placebo for Adults With Social Anxiety Disorder
The goal of this clinical trial is to learn if Caplyta works to treat Social Anxiety Disorder in adults. The main question it aims to answer is: Does Caplyta lower the frequency/severity of social anxiety symptoms in adults? Researchers will compare Caplyta to a placebo (a look-alike substance that contains no drug) to see if Caplyta works to treat Social Anxiety Disorder. Participants will: Take Caplyta or a placebo every day for 8 weeks Visit the clinic once every week for checkups and tests
Male and female adults between 18 and 65 years of age (inclusive). [+6]
Subjects with any Axis I disorder other than SAD (e.g., post-traumatic stress di... [+18]